Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand

Gestational Diabetes Mellitus (GDM) is defined as any glucose intolerance with the onset or first recognition during pregnancy. This definition helps for diagnosis of unrecognized pre-existing Diabetes also. Hyperglycemia in pregnancy is associated with adverse maternal and prenatal outcome. It is...

Full description

Bibliographic Details
Main Authors: P. Reddi Rani, Jasmina Begum
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
who
Online Access:https://jcdr.net/articles/PDF/7689/17588_CE(RA1)_F(T)_PF1(Ro_Om)_PFA(AK)_PF2(PAG).pdf
id doaj-26dfda54526944788ccf35062873583f
record_format Article
spelling doaj-26dfda54526944788ccf35062873583f2020-11-25T02:51:09ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-04-01104QE01QE0410.7860/JCDR/2016/17588.7689Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We StandP. Reddi Rani0Jasmina Begum1Professor, Department of Obstetrics & Gynecology, Mahatama Gandhi Medical College and Research Institute, Pillaiyarkuppam, Puducherry, India.Associate Professor, Department of Obstetrics & Gynecology, Mahatama Gandhi Medical College and Research Institute, Pillaiyarkuppam, Puducherry, India.Gestational Diabetes Mellitus (GDM) is defined as any glucose intolerance with the onset or first recognition during pregnancy. This definition helps for diagnosis of unrecognized pre-existing Diabetes also. Hyperglycemia in pregnancy is associated with adverse maternal and prenatal outcome. It is important to screen, diagnose and treat Hyperglycemia in pregnancy to prevent an adverse outcome. There is no international consensus regarding timing of screening method and the optimal cut-off points for diagnosis and intervention of GDM. DIPSI recommends non-fasting Oral Glucose Tolerance Test (OGTT) with 75g of glucose with a cut-off of ≥ 140 mg/dl after 2-hours, whereas WHO (1999) recommends a fasting OGTT after 75g glucose with a cut-off plasma glucose of ≥ 140 mg/dl after 2-hour. The recommendations by ADA/IADPSG for screening women at risk of diabetes is as follows, for first and subsequent trimester at 24-28 weeks a criteria of diagnosis of GDM is made by 75 g OGTT and fasting 5.1mmol/l, 1 hour 10.0mmol/l, 2 hour 8.5mmol/l by universal glucose tolerance testing. Critics of these criteria state that it causes over diagnosis of GDM and unnecessary interventions, the controversy however continues. The ACOG still prefer a 2 step procedure, GCT with 50g glucose non-fasting if value > 7.8mmol/l followed by 3-hour OGTT for confirmation of diagnosis. In conclusion based on Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study as mild degree of dysglycemia are associated with adverse outcome and high prevalence of Type II DM to have international consensus It recommends IADPSG criteria, though controversy exists. The IADPSG criteria is the only outcome based criteria, it has the ability to diagnose and treat GDM earlier, thereby reducing the fetal and maternal complications associated with GDM. This one step method has an advantage of simplicity in execution, more patient friendly, accurate in diagnosis and close to international consensus. Keeping in the mind the diversity and variability of Indian population, judging international criteria may not be conclusive, thus further comparative studies are required on different diagnostic criteria in relation to adverse pregnancy outcomes.https://jcdr.net/articles/PDF/7689/17588_CE(RA1)_F(T)_PF1(Ro_Om)_PFA(AK)_PF2(PAG).pdfcriteriadipsiiadpsgoutcomewho
collection DOAJ
language English
format Article
sources DOAJ
author P. Reddi Rani
Jasmina Begum
spellingShingle P. Reddi Rani
Jasmina Begum
Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
Journal of Clinical and Diagnostic Research
criteria
dipsi
iadpsg
outcome
who
author_facet P. Reddi Rani
Jasmina Begum
author_sort P. Reddi Rani
title Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
title_short Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
title_full Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
title_fullStr Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
title_full_unstemmed Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
title_sort screening and diagnosis of gestational diabetes mellitus, where do we stand
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2016-04-01
description Gestational Diabetes Mellitus (GDM) is defined as any glucose intolerance with the onset or first recognition during pregnancy. This definition helps for diagnosis of unrecognized pre-existing Diabetes also. Hyperglycemia in pregnancy is associated with adverse maternal and prenatal outcome. It is important to screen, diagnose and treat Hyperglycemia in pregnancy to prevent an adverse outcome. There is no international consensus regarding timing of screening method and the optimal cut-off points for diagnosis and intervention of GDM. DIPSI recommends non-fasting Oral Glucose Tolerance Test (OGTT) with 75g of glucose with a cut-off of ≥ 140 mg/dl after 2-hours, whereas WHO (1999) recommends a fasting OGTT after 75g glucose with a cut-off plasma glucose of ≥ 140 mg/dl after 2-hour. The recommendations by ADA/IADPSG for screening women at risk of diabetes is as follows, for first and subsequent trimester at 24-28 weeks a criteria of diagnosis of GDM is made by 75 g OGTT and fasting 5.1mmol/l, 1 hour 10.0mmol/l, 2 hour 8.5mmol/l by universal glucose tolerance testing. Critics of these criteria state that it causes over diagnosis of GDM and unnecessary interventions, the controversy however continues. The ACOG still prefer a 2 step procedure, GCT with 50g glucose non-fasting if value > 7.8mmol/l followed by 3-hour OGTT for confirmation of diagnosis. In conclusion based on Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study as mild degree of dysglycemia are associated with adverse outcome and high prevalence of Type II DM to have international consensus It recommends IADPSG criteria, though controversy exists. The IADPSG criteria is the only outcome based criteria, it has the ability to diagnose and treat GDM earlier, thereby reducing the fetal and maternal complications associated with GDM. This one step method has an advantage of simplicity in execution, more patient friendly, accurate in diagnosis and close to international consensus. Keeping in the mind the diversity and variability of Indian population, judging international criteria may not be conclusive, thus further comparative studies are required on different diagnostic criteria in relation to adverse pregnancy outcomes.
topic criteria
dipsi
iadpsg
outcome
who
url https://jcdr.net/articles/PDF/7689/17588_CE(RA1)_F(T)_PF1(Ro_Om)_PFA(AK)_PF2(PAG).pdf
work_keys_str_mv AT preddirani screeninganddiagnosisofgestationaldiabetesmellituswheredowestand
AT jasminabegum screeninganddiagnosisofgestationaldiabetesmellituswheredowestand
_version_ 1724736019452919808